Article: ASTELIN(R) (Azelastine Hydrochloride) Nasal Spray Effective in Patients Whose Allergy Symptoms Responded Inadequately to Treatment With Allegra(R); Clinical Data Published in Leading Medical Journal as Fall Allergy Season Begins.

SOMERSET, N.J., Aug. 16 /PRNewswire/ -- ASTELIN(R) Nasal Spray provided effective symptom relief for patients with moderate-to-severe seasonal allergic rhinitis who had an unsatisfactory response to treatment with Allegra(R) (fexofenadine hydrochloride), according to a clinical study published in the August issue of Annals of Allergy, Asthma & Immunology.

"Our findings show that ASTELIN is an effective treatment option for patients with seasonal allergic rhinitis who do not respond well to fexofenadine," reported Craig LaForce, MD, study investigator and Medical Director, North Carolina Clinical Research. "In fact, ASTELIN is an excellent alternative for patients who ...

Related newspaper, magazine, and journal articles:

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!